Market Trends Merck expects Keytruda to face HHS price setting in 2026 (MRK:NYSE)By admin8996erT0allFebruary 25, 2025 Sundry PhotographyMerck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting…
Market Trends Merck sees 2025 launch for Keytruda injectable (MRK:NYSE)By admin8996erT0allJanuary 14, 2025 Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication Keytruda…
